Found 8 matching trials
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
PHASE1CCR2 is a significant prognostic biomarker in head and neck cancer. Current...
Location
Washington University School of Medicine
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
PHASE2This is a prospective study to evaluate the sensitivity and specificity of ...
Location
Washington University School of Medicine
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
PHASE1Currently there is no clinical biomarker that can be used to select patient...
Location
Washington University School of Medicine
PET Detection of CCR2 in Human Atherosclerosis
PHASE1: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial ath...
Location
Washington University CCIR
NIH CCR2 AAA Study
EARLY_PHASE1Abdominal aortic aneurysm (AAA) is a degenerative vascular disease, which i...
Location
Washington University School of Medicine
Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)
N/AThis research study is being conducted to test how an imaging drug called 6...
Location
Penn Medicine; Perelman School of Medicine
Evaluation of CCR2 in Patients Post Myocardial Infarction
PHASE1To determine the feasibility of 64Cu-DOTA-ECL1i, an investigational PET ima...
Location
Washington University School of Medicine
CCR2 AAA Pilot Study
EARLY_PHASE1The purpose of this research study is to look at whether an investigational...
Location
Washington University School of Medicine